Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single‐arm study

Abstract Purpose In the present study, we aimed to evaluate the efficacy and safety of camrelizumab combined with oxaliplatin plus S‐1 in patients with resectable gastric or gastroesophageal junction cancer. Methods In this single‐arm, phase II clinical trial, patients with locally advanced gastric...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Wen‐Jin Zhong, Jian‐An Lin, Chu‐Ying Wu, Jian‐Tian Wang, Jun‐Xing Chen, Hui‐Da Zheng, Kai Ye
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-02-01
Serie:	Cancer Medicine
Soggetti:	Camrelizumab gastric cancer gastroesophageal junction cancer immune checkpoint inhibitor Neoadjuvant therapy S‐1
Accesso online:	https://doi.org/10.1002/cam4.7006
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!